Literature DB >> 15944142

The serotonin-1Dbeta receptor gene and severity of obsessive-compulsive disorder in women with bulimia nervosa.

R D Levitan1, A S Kaplan, M Masellis, V S Basile, M A Richter, J L Kennedy.   

Abstract

BACKGROUND: There is significant evidence that eating disorders have an important biological overlap with obsessive-compulsive disorder (OCD), though the specific mediators of this relationship remain unclear. Recent evidence suggests that the G861C polymorphism of the 5HT-1Dbeta receptor gene and the G allele in particular may play a role in OCD. We thus hypothesized that, among a heterogenous group of probands with bulimia nervosa (BN), this same G allele might predict the presence and/or severity of OCD pathology.
METHODS: 165 consecutive female probands with BN were genotyped for the G861C polymorphism of the 5HT-1Dbeta receptor gene. Rates of full syndrome OCD, partial syndrome OCD and no OCD were compared across the three genotypic groups defined by this polymorphism.
RESULTS: 45 out of 165 BN probands (27.3%) had either full or partial syndrome OCD. In the full sample, there was a significant difference in the distribution of the three diagnostic groups by genotype (chi2=10.07, df=4, p=.039). The G861C polymorphism did not strongly predict which probands had any vs. no OCD pathology. However, among the 45 probands with OCD symptoms, the G861C polymorphism did strongly differentiate full syndrome vs. partial syndrome OCD (chi2=9.26, df=2, p=.01; odds ratio for full syndrome OCD with GG genotype=7.69, 95% CI=1.45-40.9). DISCUSSION: In women with BN, the G861C polymorphism of the 5HT-1Dbeta gene does not appear to be associated with the generation of OCD symptoms; however, it might directly or indirectly be associated with a modulatory effect on syndrome severity in probands otherwise predisposed to OCD. While preliminary and in need of replication in other samples, this is the first association study to suggest how a particular gene might influence OCD pathology in an eating disorder population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944142     DOI: 10.1016/j.euroneuro.2005.04.016

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  4 in total

1.  SSRI response in depression may be influenced by SNPs in HTR1B and HTR1A.

Authors:  Sandra M Villafuerte; Kamala Vallabhaneni; Elzbieta Sliwerska; Francis J McMahon; Elizabeth A Young; Margit Burmeister
Journal:  Psychiatr Genet       Date:  2009-12       Impact factor: 2.458

Review 2.  HTR1B as a risk profile maker in psychiatric disorders: a review through motivation and memory.

Authors:  Antonio Drago; Silvia Alboni; Nicoletta Brunello; Brunello Nicoletta; Diana De Ronchi; Alessandro Serretti
Journal:  Eur J Clin Pharmacol       Date:  2009-10-07       Impact factor: 2.953

3.  Regulation of systemic energy homeostasis by serotonin in adipose tissues.

Authors:  Chang-Myung Oh; Jun Namkung; Younghoon Go; Ko Eun Shong; Kyuho Kim; Hyeongseok Kim; Bo-Yoon Park; Ho Won Lee; Yong Hyun Jeon; Junghan Song; Minho Shong; Vijay K Yadav; Gerard Karsenty; Shingo Kajimura; In-Kyu Lee; Sangkyu Park; Hail Kim
Journal:  Nat Commun       Date:  2015-04-13       Impact factor: 14.919

4.  A family-based association study of the HTR1B gene in eating disorders.

Authors:  Sandra Hernández; Beatriz Camarena; Laura González; Alejandro Caballero; Griselda Flores; Alejandro Aguilar
Journal:  Braz J Psychiatry       Date:  2016 Jul-Sep       Impact factor: 2.697

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.